Cargando…

Prostate Cancer Aggressiveness Prediction Using CT Images

Prostate Cancer (PCa) is mostly asymptomatic at an early stage and often painless requiring active surveillance screening. Transrectal Ultrasound Guided Biopsy (TRUS) is the principal method to diagnose PCa following a histological examination by observing cell pattern irregularities and assigning t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendes, Bruno, Domingues, Inês, Silva, Augusto, Santos, João
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618689/ https://www.ncbi.nlm.nih.gov/pubmed/34833040 http://dx.doi.org/10.3390/life11111164

Ejemplares similares

Value of handcrafted and deep radiomic features towards training robust machine learning classifiers for prediction of prostate cancer disease aggressiveness
por: Rodrigues, Ana, et al.
Publicado: (2023)

An Iterative Algorithm for Semisupervised Classification of Hotspots on Bone Scintigraphies of Patients with Prostate Cancer
por: Providência, Laura, et al.
Publicado: (2021)

Prediction of Prostate Cancer Disease Aggressiveness Using Bi-Parametric Mri Radiomics
por: Rodrigues, Ana, et al.
Publicado: (2021)

Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022)

Can we use Ki67 expression to predict prostate cancer aggressiveness?
por: MAIA, RONALDO, et al.
Publicado: (2022)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Editorial: Combining multiple non-invasive images and/or biochemical tests to predict prostate cancer aggressiveness
por: Mayer, Rulon, et al.
Publicado: (2023)

PET/CT imaging in prostate cancer
por: Barwick, Tara
Publicado: (2015)

Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI
por: Bertelli, Elena, et al.
Publicado: (2022)

Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness
por: Chen, Ji, et al.
Publicado: (2012)

Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT
por: Regula, Naresh, et al.
Publicado: (2020)

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples
por: Olivan, Mireia, et al.
Publicado: (2021)

Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
por: Morote, Juan, et al.
Publicado: (2014)

KLK3 SNP–SNP interactions for prediction of prostate cancer aggressiveness
por: Lin, Hui-Yi, et al.
Publicado: (2021)

ARHGEF38 as a novel biomarker to predict aggressive prostate cancer
por: Liu, Kun, et al.
Publicado: (2019)

Automated detection of aggressive and indolent prostate cancer on magnetic resonance imaging
por: Seetharaman, Arun, et al.
Publicado: (2021)

Evaluation of Peripheral Zone Prostate Cancer Aggressiveness Using the Ratio of Diffusion Tensor Imaging Measures
por: Onay, Aslihan, et al.
Publicado: (2017)

Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness
por: Damascelli, Anna, et al.
Publicado: (2021)

Association of prostate volume with incidence and aggressiveness of prostate cancer
por: Al-Khalil, Shadi, et al.
Publicado: (2016)

Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
por: Pizurica, Marija, et al.
Publicado: (2023)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancer
por: Lage-Vickers, Sofia, et al.
Publicado: (2021)

Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation
por: Faviana, Pinuccia, et al.
Publicado: (2022)

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients
por: KC, Madhav, et al.
Publicado: (2022)

Expression of NORAD correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapy
por: Alves-Vale, Catarina, et al.
Publicado: (2023)

Prediction of prostate cancer aggressiveness using (18)F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
por: Movahedi, Parisa, et al.
Publicado: (2020)

Mitochondrial mutations drive prostate cancer aggression
por: Hopkins, Julia F., et al.
Publicado: (2017)

Multi‐Site Concordance of Diffusion‐Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness
por: McGarry, Sean D., et al.
Publicado: (2021)

Blood-Based Biomarkers of Aggressive Prostate Cancer
por: Liong, Men Long, et al.
Publicado: (2012)

Evaluation of protein biomarkers of prostate cancer aggressiveness
por: Rizzardi, Anthony E, et al.
Publicado: (2014)

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts
por: Mesquita, Diana, et al.
Publicado: (2015)

The Impact of (18)F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study
por: Kim, Jae Yoon, et al.
Publicado: (2021)

AI in Breast Cancer Imaging: A Survey of Different Applications
por: Mendes, João, et al.
Publicado: (2022)

Oxidative stress adaptation in aggressive prostate cancer may be counteracted by the reduction of glutathione reductase
por: Freitas, Mariana, et al.
Publicado: (2012)

Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?
por: Santos, Pedro Bargão, et al.
Publicado: (2020)

Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2021)

Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients
por: Ali, Hamdy E. A., et al.
Publicado: (2018)

Serum Fucosylated Prostate-specific Antigen (PSA) Improves the Differentiation of Aggressive from Non-aggressive Prostate Cancers
por: Li, Qing Kay, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_op4kd9mmcdii1i4l2c0pv5aatf